Wednesday, July 9, 2025
13.7 C
London
HomeFinTechMedlab Clinical: Recieves Australian patent for NanoCelle

Medlab Clinical: Recieves Australian patent for NanoCelle

Date:

Revolut Expands Services: Users Can Now Send Money to China via Alipay

Revolut Enhances Global Transactions with New Alipay Integration for...

Consultation on the Future of Australian A2A Payments by AusPayNet and AP

Exploring Innovations and Developments in Account-to-Account Payment SystemsHighlights: AusPayNet...

CastellumAI Raises $8.5M to Revolutionize AI in Real Estate

Empowering Real Estate with Innovative Artificial Intelligence SolutionsHighlights: CastellumAI...
  • Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
  • Essentially, NanoCelle delivers drug formulations via an oral spray
  • So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
  • It can also potentially lower drug dosages and reduce the side effects of some formulations
  • Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
  • On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories